|
|
|
| Safety of tirofiban in patients with acute cerebral infarct receiving endovascular therapy |
| FENG Xuewen1,2, CHEN Zhicai1, ZHONG Genlong1, LOU Min1 |
1. Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China;
2. Department of Neurology, the First People's Hospital of Wenling, Wenling 317500, China |
|
|
|
Abstract Objective:To investigate the effect of tirofiban on hemorrhagic transformation and neurological outcome in patients with acute cerebral infarct treated with endovascular therapy. Methods:One hundred and fifteen patients with acute cerebral infarct who received endovascular stent mechanical thrombectomy in the Second Affiliated Hospital, Zhejiang University School of Medicine during October 2013 and April 2017 were included in the study. Among 115 patients, 30 received tirofiban treatment. Hemorrhagic transformation and neurological outcomes were assessed using the ECASS Ⅱ criteria and modified Rankin scale (mRS), respectively. Unfavorable outcome was defined as mRS>2. Binary logistic regression model was used to analyze the independent predictors of hemorrhagic transformation and neurological outcome. Results:Binary logistic regression analysis showed that tirofiban treatment did not increase the risk of hemorrhagic transformation (OR=0.437, 95% CI:0.168-1.132, P>0.05); baseline NIHSS (OR=1.136, 95% CI:1.014-1.273, P<0.05), recanalization (OR=0.060, 95% CI:0.010-0.365, P<0.01), hypertension (OR=4.233, 95% CI:1.320-13.570, P<0.05) and onset to treatment time(OR=1.006, 95% CI:1.001-1.011, P<0.05) were independently associated with unfavorable outcome, while such association was not observed in tirofiban treatment (OR=1.923, 95% CI:0.536-6.568, P>0.05). Conclusion:Tirofiban appears to be safe for patients with acute cerebral infarct receiving endovascular therapy.
|
|
Received: 17 March 2017
Published: 25 August 2017
|
|
|
急性缺血性卒中患者血管内治疗后应用替罗非班的安全性及预后分析
目的：探讨急性缺血性卒中患者血管内治疗后使用替罗非班的安全性及预后分析。方法：回顾性分析2013年10月至2017年4月在浙江大学医学院附属第二医院接受静脉溶栓桥接动脉取栓或直接动脉取栓的急性缺血性卒中患者115例的临床资料。根据患者术后24 h内是否使用替罗非班治疗分为替罗非班组（30例）和对照组（85例）。参照欧洲协作性急性卒中研究（ECASS）Ⅱ标准评估24 h内的出血转化，治疗后3个月时改良Rankin量表（mRS）超过2分定义为预后不优。采用二元logistic回归分析治疗后使用替罗非班是否独立影响患者出血转化和3个月临床预后。结果：二元logistic回归分析提示，替罗非班治疗不增加出血转化的风险（OR=0.437，95%CI：0.168~1.132，P>0.05）；患者基线美国国立卫生研究院卒中量表（NIHSS）评分（OR=1.136，95%CI：1.014~1.273，P<0.05）、血管再通（OR=0.060，95%CI：0.010~0.365，P<0.01）、高血压（OR=4.233，95%CI：1.320~13.570，P<0.05）和起病至治疗时间（OR=1.006，95% CI：1.001~1.011，P<0.05）与临床预后不优独立相关，而替罗非班治疗与临床预后不优无独立相关性（OR=1.923，95%CI：0.536~6.568，P>0.05）。结论：急性缺血性卒中患者血管内治疗后使用替罗非班不会增加出血转化的风险。
关键词：
动脉闭塞性疾病/药物疗法,
脑缺血/治疗,
血栓溶解疗法,
酪氨酸/类似物和衍生物,
血小板膜糖蛋白类/拮抗剂和抑制剂,
出血/预防和控制,
预后
|
|
| [1] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. Chinese Medical Association Neurology Branch for Diagnosis and Treatment of Acute Ischemic Stroke. Guidelines for diagnosis and treatment of acute ischemic stroke in China[J]. Chinese Journal of Neurology,2010,43(2):146-153. (in Chinese)
[2] 赵伟,侯延伟,张合亮,等.基底动脉闭塞患者静脉溶栓和联合机械取栓的差异性研究[J].中华老年心脑血管病杂志,2016,18(2):179-181. ZHAO Wei, HOU Yanwei, ZHANG Heliang, et al. Effect of intravenous thrombolysis and combined mechanical thrombectomy on basilar artery occlusion[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases,2016,18(2):179-181. (in Chinese)
[3] CAMPBELL B C, MITCHELL P J, KLEINIG T J, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018.
[4] 中国卒中学会重症脑血管病分会专家撰写组.急性缺血性脑卒中血管内治疗术后监护与管理中国专家共识[J].中华医学杂志,2017,97(3):162-172. Chinese Stroke Society of Critical Cerebrovascular Disease. Consultation and management of postoperative patients with acute ischemic stroke[J]. National Medical Journal of China,2017,97(3):162-172. (in Chinese)
[5] BAIK S K, OH S J, PARK K P, et al. Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke[J]. Interv Neuroradiol,2011,17(4):442-451.
[6] JUNGHANS U, SEITZ R J, AULICH A, et al. Bleeding risk of tirofiban, a nonpeptide GPⅡb/Ⅲa platelet receptor antagonist in progressive stroke:an open pilot study[J]. Cerebrovasc Dis,2001,12(4):308-312.
[7] SEO J H, JEONG H W, KIM S T, et al. Adjuvant tirofiban injection through deployed solitaire stent as a rescue technique after failed mechanical thrombectomy in acute stroke[J]. Neurointervention,2015,10(1):22-27.
[8] KELLERT L, HAMETNER C, ROHDE S, et al. Endovascular stroke therapy:tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome[J]. Stroke,2013,44(5):1453-1455.
[9] 严慎强,毛颖盈,钟根龙,等.既往抗血小板治疗对合并颅内微出血急性缺血性卒中患者静脉溶栓的安全性分析[J].浙江大学学报(医学版),2015,44(6):618-624. YAN Shenqiang, MAO Yingying, ZHONG Genlong, et al. Safety of intravenous thrombolysis in cerebral microbleeds patients with prior antiplatelet therapy[J]. Journal of Zhejiang University (Medical Sciences),2015,44(6):618-624. (in Chinese)
[10] VERGOUWEN M D, ALGRA A, PFEFFERKORN T, et al. Time is brain(stem) in basilar artery occlusion[J]. Stroke,2012,43(11):3003-3006.
[11] LARRUE V, VON K R R, MVLLER A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ)[J]. Stroke,2001,32(2):438-441.
[12] CAMPBELL B C, CHRISTENSEN S, LEVI C R, et al. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke[J]. Stroke,2012,43(10):2648-2653.
[13] ROHDE S, HAEHNEL S, HERWEH C, et al. Mechanical thrombectomy in acute embolic stroke:preliminary results with the revive device[J]. Stroke,2011,42(10):2954-2956.
[14] LI W, LIN L, ZHANG M, et al. Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients[J]. Stroke,2016,47(10):2649-2651.
[15] 李坷,张继中,张钦昌.国产替罗非班在急性进展性缺血性卒中治疗中的应用[J].中国实用神经疾病杂志,2017,20(1):117-118. LI Ke, ZHANG Jizhong, ZHANG Qinchang. Application of domestic tirofiban in the treatment of acute progressive cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases,2017,20(1):117-118. (in Chinese)
[16] SEITZ R J, MEISEL S, MOLL M, et al. The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions[J]. Neurology,2004,62(11):2110-2112.
[17] MALIK A M, VORA N A, LIN R, et al. Endovascular treatment of tandem extracranial/intracranial anterior circulation occlusions:preliminary single-center experience[J]. Stroke,2011,42(6):1653-1657.
[18] 张全新.急性缺血性卒中动脉溶栓与机械取栓后24 h内应用低分子肝素抗凝治疗的临床研究[J].泰山医学院学报,2014,35(6):485-488. ZHANG Quanxin. Clinical research of the effect of low molecule weight heparin anticoagulation within 24h on acute cerebral infarction patients treatedwith arterial thrombolysis and mechanical thrombectomy[J]. Journal of Taishan Medical College,2014,35(6):485-488. (in Chinese)
[19] 杜娟,崔永强,吴铮,等.急性缺血性卒中动脉内机械取栓困难的临床分析[J].中华外科杂志,2016,54(5):335-339. DU Juan, CUI Yonqiang, WU Zheng, et al. Clinical analysis of difficult intraarterial mechanical thrombectomy in patients with acute ischemic stroke[J]. Chinese Journal of Surgery,2016,54(5):335-339. (in Chinese) |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
